HUTCHMED (China) (HCM) Cost of Revenue: 2018-2021

Historic Cost of Revenue for HUTCHMED (China) (HCM) over the last 2 years, with Jun 2021 value amounting to $12.3 million.

  • HUTCHMED (China)'s Cost of Revenue rose 298.64% to $12.3 million in Q2 2021 from the same period last year, while for Jun 2021 it was $23.7 million, marking a year-over-year increase of 99.06%. This contributed to the annual value of $348.9 million for FY2024, which is 9.25% down from last year.
  • Per HUTCHMED (China)'s latest filing, its Cost of Revenue stood at $12.3 million for Q2 2021, which was up 114.09% from $5.7 million recorded in Q1 2021.
  • HUTCHMED (China)'s Cost of Revenue's 5-year high stood at $12.3 million during Q2 2021, with a 5-year trough of $2.1 million in Q4 2019.
  • Over the past 3 years, HUTCHMED (China)'s median Cost of Revenue value was $3.8 million (recorded in 2019), while the average stood at $4.7 million.
  • In the last 5 years, HUTCHMED (China)'s Cost of Revenue crashed by 49.40% in 2019 and then surged by 298.64% in 2021.
  • Quarterly analysis of 4 years shows HUTCHMED (China)'s Cost of Revenue stood at $4.1 million in 2018, then crashed by 49.40% to $2.1 million in 2019, then decreased by 17.14% to $3.1 million in 2020, then spiked by 298.64% to $12.3 million in 2021.
  • Its Cost of Revenue stands at $12.3 million for Q2 2021, versus $5.7 million for Q1 2021 and $3.1 million for Q2 2020.